- Home
- NBIX vs AEG Comparison
NBIX vs AEG Comparison
Compare NBIX & AEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBIX | AEG |
|---|---|---|
| Founded | 1992 | 1983 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 12.0B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | NBIX | AEG |
|---|---|---|
| Price | $151.98 | $8.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 18 | 0 |
| Target Price | ★ $172.33 | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 5.5M |
| Earning Date | 10-28-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.68% |
| EPS Growth | ★ 12.44 | N/A |
| EPS | ★ 4.19 | 0.93 |
| Revenue | $2,682,700,000.00 | ★ $15,344,685,849.00 |
| Revenue This Year | $23.68 | N/A |
| Revenue Next Year | $18.02 | $2.04 |
| P/E Ratio | $36.30 | ★ $8.49 |
| Revenue Growth | ★ 19.61 | 2.83 |
| 52 Week Low | $84.23 | $5.42 |
| 52 Week High | $157.67 | $8.15 |
Technical Indicators
Market Signals| Indicator | NBIX | AEG |
|---|---|---|
| Relative Strength Index (RSI) | 61.79 | 66.01 |
| Support Level | $139.27 | $7.45 |
| Resistance Level | $144.83 | $7.61 |
| Average True Range (ATR) | 4.59 | 0.10 |
| MACD | 0.49 | 0.04 |
| Stochastic Oscillator | 88.14 | 98.33 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About AEG Aegon Ltd. New York Registry Shares
Aegon is a life insurance and long-term savings business listed in the Netherlands. It listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, the United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. Over recent years, Aegon has been moving through an extensive transformation program where management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the group that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile-earnings products and recycle funds into capital-light and more predictable strategic businesses.